X-盒结合蛋白1(X-box binding protein 1,XBP-1)是一种新近发现的与蛋白质折叠和内质网构建相关的蛋白质,研究发现其在多种肿瘤细胞中均有广泛表达,与肿瘤发生、发展的关系密切。本文对XBP-1参与肿瘤发生、发展过程的免疫逃避、血管生...X-盒结合蛋白1(X-box binding protein 1,XBP-1)是一种新近发现的与蛋白质折叠和内质网构建相关的蛋白质,研究发现其在多种肿瘤细胞中均有广泛表达,与肿瘤发生、发展的关系密切。本文对XBP-1参与肿瘤发生、发展过程的免疫逃避、血管生成、缺氧、侵袭转移等方面的研究进展做一综述。展开更多
Lipotoxicity is a pivotal factor that initiates and exacerbates liver injury and is involved in the development of metabolic-associated fatty liver disease(MAFLD).However,there are few reported lipotoxicity inhibitors...Lipotoxicity is a pivotal factor that initiates and exacerbates liver injury and is involved in the development of metabolic-associated fatty liver disease(MAFLD).However,there are few reported lipotoxicity inhibitors.Here,we identified a natural anti-lipotoxicity candidate,HN-001,from the marine fungus Aspergillus sp.C1.HN-001 dose-and time-dependently reversed palmitic acid(PA)-induced hepatocyte death.This protection was associated with IRE-1a-mediated XBP-1 splicing inhibition,which resulted in suppression of XBP-1s nuclear translocation and transcriptional regulation.Knockdown of XBP-1s attenuated lipotoxicity,but no additional ameliorative effect of HN-001 on lipotoxicity was observed in XBP-1s knockdown hepatocytes.Notably,the ER stress and lipotoxicity amelioration was associated with PLA2.Both HN-001 and the PLA2 inhibitor MAFP inhibited PLA2 activity,reduced lysophosphatidylcholine(LPC)level,subsequently ameliorated lipotoxicity.In contrast,overexpression of PLA2 caused exacerbation of lipotoxicity and weakened the anti-lipotoxic effects of HN-001.Additionally,HN-001 treatment suppressed the downstream pro-apoptotic JNK pathway.In vivo,chronic administration of HN-001(i.p.)in mice alleviated all manifestations of MAFLD,including hepatic steatosis,liver injury,inflammation,and fibrogenesis.These effects were correlated with PLA2/IRE-1a/XBP-1s axis and JNK signaling suppression.These data indicate that HN-001 has therapeutic potential for MAFLD because it suppresses lipotoxicity,and provide a natural structural basis for developing anti-MAFLD candidates.展开更多
目的:探讨内质网氧化还原酶-1α(endoplasmic reticulum oxidoreductin 1α,ERO1α)在同型半胱氨酸(homocysteine,Hcy)诱导的肝细胞内质网应激(endoplasmic reticulum stress,ERS)中的作用及机制.方法:培养人肝细胞,用Hcy(100μmol/L)干...目的:探讨内质网氧化还原酶-1α(endoplasmic reticulum oxidoreductin 1α,ERO1α)在同型半胱氨酸(homocysteine,Hcy)诱导的肝细胞内质网应激(endoplasmic reticulum stress,ERS)中的作用及机制.方法:培养人肝细胞,用Hcy(100μmol/L)干预,同时设对照组,使用酶联免疫法(ELISA)检测ERS相关蛋白葡萄糖调节蛋白78(glucoseregulated protein 78,GRP78)、X盒结合蛋白-1(X-box binding protein-1,XBP-1)、内质网类似激酶(protein kinase RNA-like endoplasmic r e t i c u l u m k i n a s e,P E R K)及激活转录因子6(activating transcription factor 6,ATF6)的水平;用不同浓度Hcy(0、50、100、200、500μmol/L)和100μmol/L Hcy+叶酸+维生素B12(VB12)干预,运用实时定量PCR和Western blot检测ERO1αm RNA和蛋白水平;构建ERO1α基因重组质粒和RNA干扰片段并感染肝细胞,检测ERO1αm RNA和蛋白表达变化;采用ELISA法检测其对ERS相关蛋白的调控作用.结果:与对照组比较,Hcy组GRP78、ATF6、P E R K、X B P-1水平升高(P<0.01,P<0.01,P<0.05,P<0.01);不同浓度Hcy干预后,肝细胞内ERO1αm RNA及蛋白水平呈下降趋势,且随着Hcy浓度的增加而减少(P<0.01),呈剂量依赖关系;将ERO1α重组质粒转染肝细胞后,ERO1αm RNA及蛋白表达明显增加(P<0.01);将三个不同的ERO1αsi RNA片段转染肝细胞后,ERO1αm RNA及蛋白表达降低(P<0.01),其中si RNA2作用最明显(P<0.01);与Hcy组相比,Hcy+p ERO1α组GRP78、XBP-1、PERK及ATF6均明显降低(P<0.01),而Hcy+si RNA2组均明显升高(P<0.01).结论:Hcy可能通过下调ERO1α引起肝细胞GRP78-XBP-1/PERK/ATF6表达增加促进ERS发生.展开更多
文摘X-盒结合蛋白1(X-box binding protein 1,XBP-1)是一种新近发现的与蛋白质折叠和内质网构建相关的蛋白质,研究发现其在多种肿瘤细胞中均有广泛表达,与肿瘤发生、发展的关系密切。本文对XBP-1参与肿瘤发生、发展过程的免疫逃避、血管生成、缺氧、侵袭转移等方面的研究进展做一综述。
基金This study was supported by National Natural Science Foundation of China(82260674 to Yong Rao,82160653 to Ling Huang)Fundamental Research Funds for Hainan University(KYQD(ZR)-21114 to Yong Rao,KYQD(ZR)-21089 to Ling Huang,China)+2 种基金Hainan Provincial Natural Science Foundation of China(822MS054 to Yong Rao)Natural Science Foundation of Guangdong Province(2021A1515010488 to Yong Rao,China)Central Public-interest Scientific Institution Basal Research Fund for CATAS-ITBB(1630052022016,1630052019011,China).
文摘Lipotoxicity is a pivotal factor that initiates and exacerbates liver injury and is involved in the development of metabolic-associated fatty liver disease(MAFLD).However,there are few reported lipotoxicity inhibitors.Here,we identified a natural anti-lipotoxicity candidate,HN-001,from the marine fungus Aspergillus sp.C1.HN-001 dose-and time-dependently reversed palmitic acid(PA)-induced hepatocyte death.This protection was associated with IRE-1a-mediated XBP-1 splicing inhibition,which resulted in suppression of XBP-1s nuclear translocation and transcriptional regulation.Knockdown of XBP-1s attenuated lipotoxicity,but no additional ameliorative effect of HN-001 on lipotoxicity was observed in XBP-1s knockdown hepatocytes.Notably,the ER stress and lipotoxicity amelioration was associated with PLA2.Both HN-001 and the PLA2 inhibitor MAFP inhibited PLA2 activity,reduced lysophosphatidylcholine(LPC)level,subsequently ameliorated lipotoxicity.In contrast,overexpression of PLA2 caused exacerbation of lipotoxicity and weakened the anti-lipotoxic effects of HN-001.Additionally,HN-001 treatment suppressed the downstream pro-apoptotic JNK pathway.In vivo,chronic administration of HN-001(i.p.)in mice alleviated all manifestations of MAFLD,including hepatic steatosis,liver injury,inflammation,and fibrogenesis.These effects were correlated with PLA2/IRE-1a/XBP-1s axis and JNK signaling suppression.These data indicate that HN-001 has therapeutic potential for MAFLD because it suppresses lipotoxicity,and provide a natural structural basis for developing anti-MAFLD candidates.
文摘目的:探讨内质网氧化还原酶-1α(endoplasmic reticulum oxidoreductin 1α,ERO1α)在同型半胱氨酸(homocysteine,Hcy)诱导的肝细胞内质网应激(endoplasmic reticulum stress,ERS)中的作用及机制.方法:培养人肝细胞,用Hcy(100μmol/L)干预,同时设对照组,使用酶联免疫法(ELISA)检测ERS相关蛋白葡萄糖调节蛋白78(glucoseregulated protein 78,GRP78)、X盒结合蛋白-1(X-box binding protein-1,XBP-1)、内质网类似激酶(protein kinase RNA-like endoplasmic r e t i c u l u m k i n a s e,P E R K)及激活转录因子6(activating transcription factor 6,ATF6)的水平;用不同浓度Hcy(0、50、100、200、500μmol/L)和100μmol/L Hcy+叶酸+维生素B12(VB12)干预,运用实时定量PCR和Western blot检测ERO1αm RNA和蛋白水平;构建ERO1α基因重组质粒和RNA干扰片段并感染肝细胞,检测ERO1αm RNA和蛋白表达变化;采用ELISA法检测其对ERS相关蛋白的调控作用.结果:与对照组比较,Hcy组GRP78、ATF6、P E R K、X B P-1水平升高(P<0.01,P<0.01,P<0.05,P<0.01);不同浓度Hcy干预后,肝细胞内ERO1αm RNA及蛋白水平呈下降趋势,且随着Hcy浓度的增加而减少(P<0.01),呈剂量依赖关系;将ERO1α重组质粒转染肝细胞后,ERO1αm RNA及蛋白表达明显增加(P<0.01);将三个不同的ERO1αsi RNA片段转染肝细胞后,ERO1αm RNA及蛋白表达降低(P<0.01),其中si RNA2作用最明显(P<0.01);与Hcy组相比,Hcy+p ERO1α组GRP78、XBP-1、PERK及ATF6均明显降低(P<0.01),而Hcy+si RNA2组均明显升高(P<0.01).结论:Hcy可能通过下调ERO1α引起肝细胞GRP78-XBP-1/PERK/ATF6表达增加促进ERS发生.
